23
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Cisplatin and Etoposide as Second-Line Chemotherapy in Patients with Small Cell Lung Cancer

, , , , , , , , & show all
Pages 1-5 | Published online: 11 Jun 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Antonio Rossi, Paola Claudia Sacco, Assunta Sgambato, Francesca Casaluce, Giuseppe Santabarbara, Giovanni Palazzolo, Paolo Maione & Cesare Gridelli. (2016) Optimal drugs for second-line treatment of patients with small-cell lung cancer. Expert Opinion on Pharmacotherapy 17:7, pages 969-976.
Read now

Articles from other publishers (14)

Kohei Horiuchi, Takashi Sato, Toshiki Kuno, Hisato Takagi, Fred R. Hirsch, Charles A. Powell & Koichi Fukunaga. (2021) Platinum-doublet chemotherapy as second-line treatment for relapsed patients with small-cell lung cancer: A systematic review and meta-analysis. Lung Cancer 156, pages 59-67.
Crossref
Nathalie Baize, Isabelle Monnet, Laurent Greillier, Margaux Geier, Hervé Lena, Henri Janicot, Alain Vergnenegre, Jacky Crequit, Regine Lamy, Jean-Bernard Auliac, Jacques Letreut, Hervé Le Caer, Radj Gervais, Eric Dansin, Anne Madroszyk, Patrick-Aldo Renault, Gwenaëlle Le Garff, Lionel Falchero, Henri Berard, Roland Schott, Patrick Saulnier & Christos Chouaid. (2020) Carboplatin plus etoposide versus topotecan as second-line treatment for patients with sensitive relapsed small-cell lung cancer: an open-label, multicentre, randomised, phase 3 trial. The Lancet Oncology 21:9, pages 1224-1233.
Crossref
Nobuhiro Asai, Yoshihiro Ohkuni, Norihiro Kaneko, Etsuro Yamaguchi & Akihito Kubo. (2014) Relapsed small cell lung cancer: treatment options and latest developments. Therapeutic Advances in Medical Oncology 6:2, pages 69-82.
Crossref
Joao E. Bezerra, Rachel P. Riechelmann & Paulo M. Hoff. 2011. Neuroendocrine Tumors. Neuroendocrine Tumors 157 176 .
Christos Christodoulou, Haralambos P. Kalofonos, Evangelos Briasoulis, Dimitrios Bafaloukos, Thomas Makatsoris, Angelos Koutras, Dimosthenis V. Skarlos & Epaminondas Samantas. (2005) Combination of topotecan and cisplatin in relapsed patients with small cell lung cancer: a phase II study of the hellenic cooperative oncology group (HeCOG). Cancer Chemotherapy and Pharmacology 57:2, pages 207-212.
Crossref
Angela M. Davies, William K. Evans, Jean A. Mackay & Frances A. Shepherd. (2004) Treatment of recurrent small cell lung cancer. Hematology/Oncology Clinics of North America 18:2, pages 387-416.
Crossref
Joachim von Pawel. (2003) The role of topotecan in treating small cell lung cancer: second-line treatment. Lung Cancer 41, pages S3-S8.
Crossref
A. Veronesi, G. Cartel, D. CriveUari, M.D. Magri, M.Delia Valentina, S. Foladore, M.G. Trovo, O. Nascimben, A. Sibau, R. Talamini & S. Monfardini. (1994) Cisplatin and etoposide versus cyclophosphamide, epirubicin and vincristine in small cell lung cancer: a randomised study. European Journal of Cancer 30:10, pages 1474-1478.
Crossref
I. Monnet, P. Chariot, E. Quoix, P. Ruffié, S. Voisin, T. Le Chevalier, J.C. Saltiel & H. de Cremoux. (1992) Extensive small-cell lung cancer. A randomized comparison of two chemotheraphy programs with early crossover in instances of failure. Annals of Oncology 3:10, pages 813-817.
Crossref
Cesare Gridelli, Alma Contegiacomo, Rossella Lauria, Maria Gentile, Giuseppe Airoma, Sabino De Placido, Francesco Perrone, Giovanni Ferrante & Angelo Raffaele Bianco. (2018) Salvage Chemotherapy with Ccnu and Methotrexate for Small Cell Lung Cancer Resistant to Cav/Pe Alternating Chemotherapy. Tumori Journal 77:6, pages 506-510.
Crossref
Mette Andersen, Paul E.G. Kristjansen & Heine H. Hansen. (1990) Second-line chemotherapy in small cell lung cancer. Cancer Treatment Reviews 17:4, pages 427-436.
Crossref
Marcia Rostad. (1990) Advances in Nursing Management of Patients with Lung Cancer. Nursing Clinics of North America 25:2, pages 393-403.
Crossref
Giuseppe Giaccone. (1989) Second line chemotherapy in small cell lung cancer. Lung Cancer 5:4-6, pages 207-213.
Crossref
Margaret Hansen Frogge. (1989) Streamlining outpatient cisplatin therapy to meet the challenges of today. Seminars in Oncology Nursing 5:2, pages 21-28.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.